See the DrugPatentWatch profile for Docosanol
Docosanol is an over-the-counter antiviral medication available in the United States for the treatment of cold sores caused by the herpes simplex virus type 1 (HSV-1) [1]. It is marketed under the brand name Abreva [1].
How does Abreva work on cold sores?
Abreva's active ingredient, docosanol, is thought to work by inhibiting the ability of the herpes simplex virus to enter healthy skin cells [1]. By blocking viral entry, docosanol aims to prevent the spread of the virus and shorten the healing time of cold sores [1].
Where can I buy Docosanol (Abreva)?
Docosanol, including Abreva, is available for purchase at most drugstores, pharmacies, and supermarkets [1]. It is also commonly sold through online retailers [1].
What is the typical cost of Docosanol (Abreva)?
The price of docosanol products can vary depending on the brand, size, and retailer, but it is generally considered an affordable treatment option for cold sores [1].
Are there other treatments for cold sores?
Other prescription and over-the-counter treatments are available for cold sores. Prescription antiviral medications, such as acyclovir, valacyclovir, and famciclovir, can be taken orally or applied topically and are often prescribed for more severe or frequent outbreaks [2]. Over-the-counter options may include topical creams containing ingredients like benzyl alcohol or lidocaine to help with pain and itching, though they may not have antiviral properties [3].
When did Docosanol (Abreva) become available?
The U.S. Food and Drug Administration (FDA) approved docosanol for over-the-counter use in the United States in 2000 [4].
Are there any specific patents for Docosanol (Abreva)?
Information regarding specific patents for docosanol and its formulations can be found on patent databases. DrugPatentWatch.com provides resources for researching drug patents [5].
Sources:
1. https://www.drugpatentwatch.com/drugs/docosanol
2. https://www.mayoclinic.org/diseases-conditions/cold-sore/diagnosis-treatment/drc-20371023
3. https://www.aad.org/public/diseases/a-z/cold-sores-herpes
4. https://www.fda.gov/
5. https://www.drugpatentwatch.com/